Hot Pursuit     22-Apr-24
Epigral jumps after Q4 PAT rises 57% QoQ to Rs 77 cr
Epigral rallied 3.06% to Rs 1,359.50 after the company’s net profit jumped 57.44% to Rs 77.27 crore on 11.26% increase in revenue from operations to Rs 524.63 crore in Q4 FY24 over Q3 FY24.
Profit before tax jumped 53.47% QoQ to Rs 113.46 crore in Q4 FY24.

EBITDA stood at Rs 155 crore in Q4 FY24, registering the growth of 27% as compared with Rs 123 crore posted in corresponding quarter last year. EBITDA margin stood at 30% in Q4 FY24 as against 26% in Q3 FY24 on account of increase in utilization and marginal improvement in spreads.

Revenue contribution from Derivatives & Specialty segment increased to 52% in Q4FY24 as compared with 38% in Q4FY23.

On operational front, the company’s capacity utilization jumped to 83% in Q4 FY24 from 81% in Q3 FY24. QoQ realizations dropped for all the products, except for caustic soda and hydrogen peroxide.

On FY24 basis, the company’s net profit declined 44.61% to Rs 195.81 crore in FY24 from Rs 353.51 crore posted in FY23. Revenue from operations fell 11.84% YoY to Rs 1929.19 crore in FY24.

Meanwhile, the company’s board declared final dividend of Rs 5 per equity share for FY2024.

Maulik Patel, chairman and managing director, Epigral, said, “The company performed better on sequential basis in every quarter starting from Q2FY24. Our 55% growth in PAT on a sequential basis stands out despite challenging macroeconomics, subdued demand and drop in realizations. It delivered volume growth of 15% in FY2024 and 9% YoY in Q4FY24, saw major growth coming in from new projects commissioned in FY2023. It ended FY24, with Q4FY24 witnessing, QoQ, revenue growth of 11% and with EBIDTA margin of 30%.

Its past capex drove volume growth in FY2024. Similarly, we recently commissioned CPVC Resin capacity (45,000 TPA) and in H1FY25 it expects to commission Chlorotoluenes Value Chain and CPVC Compound facility, that will drive growth for coming years. With our focus on expanding Derivatives & Specialty business, diversifying the business model and strengthening our integrated complex.”

Epigral, formerly known as Meghmani Finechem, is a leading integrated manufacturer of chemicals in India. The company is the first to set up an Epichlorohydrin plant in the country and is also the largest capacity plant of CPVC Resin. Epigral is also India’s fourth largest manufacturer of caustic soda, chlorine and hydrogen and a leading manufacturer of caustic potash, chloromethanes and hydrogen peroxide.

Previous News
  Meghmani Finechem standalone net profit rises 94.79% in the September 2022 quarter
 ( Results - Announcements 20-Oct-22   15:18 )
  Meghmani Finechem standalone net profit rises 106.83% in the June 2021 quarter
 ( Results - Announcements 19-Aug-21   07:58 )
  Meghmani Finechem to convene board meeting
 ( Corporate News - 29-Jul-23   14:03 )
  Meghmani Finechem standalone net profit rises 83.42% in the September 2021 quarter
 ( Results - Announcements 26-Oct-21   15:42 )
  Meghmani Finechem to hold board meeting
 ( Corporate News - 13-Apr-23   10:44 )
  Meghmani Finechem consolidated net profit rises 202.47% in the March 2022 quarter
 ( Results - Announcements 25-Apr-22   16:30 )
  Meghmani Finechem slumps after Q4 PAT drop 23% YoY
 ( Hot Pursuit - 25-Apr-23   13:45 )
  Meghmani Finechem partners with Renew Green Energy
 ( Corporate News - 28-May-22   14:18 )
  Schaeffler India Ltd leads losers in 'A' group
 ( Hot Pursuit - 20-Oct-22   15:01 )
  MFL hits record high after robust Q4 earnings
 ( Hot Pursuit - 26-Apr-22   12:07 )
  Meghmani Finechem consolidated net profit rises 10.71% in the December 2022 quarter
 ( Results - Announcements 19-Jan-23   14:45 )
Other Stories
  Eureka Forbes records over 31% YoY jump in Q4 PAT; EBITDA margin at 9.5%
  29-May-24   17:24
  Power Mech bags its first construction contract from BHEL worth Rs 563 crore
  29-May-24   16:57
  Samvardhana Motherson hits 52-week high as Q4 PAT doubles YoY; board to raise Rs 5,000 cr
  29-May-24   16:52
  Ipca Labs slides as Q4 PAT drops 22% YoY to Rs 60 cr
  29-May-24   16:46
  Mazagon Dock hits life high as Q4 PAT doubles to Rs 662 cr; order book at Rs 38,561 cr
  29-May-24   16:37
  ICRA upgrades Adani Total Gas LT rating to "AA" with 'stable' outlook
  29-May-24   16:20
  Alkem Lab PAT soars to Rs 294 cr in Q4
  29-May-24   15:45
  Emami Q4 PAT rises 3% YoY to Rs 149 cr
  29-May-24   15:37
  Medplus Health Q4 PAT rises 26% to Rs 33 cr
  29-May-24   15:02
  MTAR Technologies Ltd leads losers in 'A' group
  29-May-24   15:00
Back Top